Akari Therapeutics (AKTX) Cash from Financing Activities (2014 - 2026)
Akari Therapeutics recorded quarterly Cash from Financing Activities of $53000.0 in Q1 2026, down 99.08% quarter-over-quarter from $5.8 million in Q4 2025, and down 97.52% year-over-year from $2.1 million in Q1 2025.
Akari Therapeutics' Cash from Financing Activities history runs 11 years deep, the most recent figure standing at $53000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 97.52% year-over-year to $53000.0; the TTM figure through Mar 2026 stood at $11.1 million (down 4.45% YoY), while the FY2025 annual figure was $13.2 million, up 19.87% from the prior year.
- Cash from Financing Activities came in at $53000.0 for Q1 2026 at Akari Therapeutics, down from $5.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $12.4 million in Q1 2022 to a low of -$443000.0 in Q3 2024.
- A 5-year average of $3.4 million and a median of $2.2 million in 2024 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 2567.7% in 2024 and tumbled 97.52% in 2026, its largest moves.
- Akari Therapeutics' Cash from Financing Activities stood at $12.4 million in 2022, then sank by 71.56% to $3.5 million in 2023, then tumbled by 38.75% to $2.2 million in 2024, then surged by 167.41% to $5.8 million in 2025, then plunged by 99.08% to $53000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $53000.0, $5.8 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 238.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,000.00 |
| Mar 31, 2026 | 53,000.00 |
| Dec 31, 2025 | 5.76 Mn |
| Dec 31, 2025 | 5.76 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | -443,000.00 |
| Sep 30, 2024 | -443,000.00 |
| Jun 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Jun 30, 2023 | 291,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 3.21 Mn |
| Mar 31, 2023 | 3.21 Mn |
| Mar 31, 2022 | 12.37 Mn |
| Mar 31, 2022 | 12.37 Mn |
| Dec 31, 2021 | -13,176.32 Bn |
| Dec 31, 2021 | -13,176.32 Bn |
| Sep 30, 2021 | 13,176.32 Bn |
| Sep 30, 2021 | 13,176.32 Bn |
| Dec 31, 2020 | -19,081.43 Bn |
| Dec 31, 2020 | -19,081.43 Bn |
| Sep 30, 2020 | 19,081.44 Bn |
| Sep 30, 2020 | 19,081.44 Bn |
| Jun 30, 2020 | -9,877.97 Bn |
| Jun 30, 2020 | -9,877.97 Bn |
| Mar 31, 2020 | 9,877.99 Bn |
| Mar 31, 2020 | 9,877.99 Bn |
| Dec 31, 2019 | 2.78 Mn |
| Dec 31, 2019 | 2.78 Mn |
| Sep 30, 2019 | 8.40 Mn |
| Sep 30, 2019 | 8.40 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Jun 30, 2019 | 1.32 Mn |
| Mar 31, 2019 | 157,743.00 |
| Mar 31, 2019 | 157,743.00 |
| Dec 31, 2018 | 153,428.00 |
| Dec 31, 2018 | 153,428.00 |
| Sep 30, 2018 | 346,572.00 |
| Sep 30, 2018 | 346,572.00 |
| Dec 31, 2015 | -3.06 Mn |
| Dec 31, 2015 | -3.06 Mn |
| Sep 30, 2015 | 72.61 Mn |
| Sep 30, 2015 | 72.61 Mn |
| Jun 30, 2015 | -508,713.00 |
| Jun 30, 2015 | -508,713.00 |
| Dec 31, 2014 | 3.89 Mn |
| Dec 31, 2014 | 3.89 Mn |
| Sep 30, 2014 | -7.88 Mn |
| Sep 30, 2014 | -7.88 Mn |
| Mar 31, 2014 | 8.22 Mn |
| Mar 31, 2014 | 8.22 Mn |